Features | Partner Sites | Information | LinkXpress
Sign In
AMPRONIX
SCHILLER AG
TERARECON, INC.

For Younger Women, Study Reveals Mammography Saves Lives

By Medimaging International staff writers
Posted on 11 Feb 2014
Image: Mammography unit. According to the study, women between ages 40 and 49 who underwent routine screening mammography were diagnosed at earlier stages with smaller tumors and were less likely to require chemotherapy (Photo courtesy of bartekwardziak / Fotolia).
Image: Mammography unit. According to the study, women between ages 40 and 49 who underwent routine screening mammography were diagnosed at earlier stages with smaller tumors and were less likely to require chemotherapy (Photo courtesy of bartekwardziak / Fotolia).
New findings have demonstrated that mammography remains beneficial for women in their 40s. According to the study, women between ages 40 and 49 who underwent routine screening mammography were diagnosed at earlier stages with smaller tumors and were less likely to require chemotherapy.

Researchers from University Hospitals (UH) Case Medical Center (Cleveland, OH, USA) and Case Western Reserve University School of Medicine (Cleveland, OH, USA) have published new findings in the February 2014 issue of American Journal of Roentgenology that mammography is an important detection tool for women in their 40s. According to the study, women between ages 40 and 49 who underwent routine screening mammography were diagnosed at earlier stages with smaller tumors and were less likely to require chemotherapy.

There have been contradictory guidelines recently related to the benefit of yearly mammograms for women in their 40s. The United States Preventive Services Task Force’s guidelines from 2009 recommend against annual screening mammography for women in that age group while the American Cancer Society, American College of Radiology, and other professional societies recommend annual exams beginning at age 40.

“Our findings clearly underscore the impact of neglecting to screen women with mammography for women in their 40s,” said the study’s first author Donna Plecha, MD, director of breast imaging at UH Case Medical Center Seidman Cancer Center and assistant professor at Case Western Reserve School of Medicine. “Foregoing mammography for women in this age group leads to diagnoses of later stage breast cancers. We continue to support screening mammography in women between the ages of 40 and 49 years.”

In the study, the authors compared two groups of women between 40 and 49 years old: women undergoing screening mammography and women with a symptom needing diagnostic workup. The researchers conducted a retrospective chart review of 230 primary breast cancers and found that patients undergoing screening mammography had substantial differences in relation to treatment recommendations, stage at diagnosis and identification of high-risk lesions than symptomatic women needing diagnostic evaluation. They determined that patients in the screened group were diagnosed at earlier stages with smaller tumors and less apt to require chemotherapy and its associated morbidities. They also revealed that screening allows identification of high-risk lesions, which may encourage chemoprevention and lower ensuing breast cancer risk.

Breast cancer is a major health problem and statistics indicate that one in eight women will develop the disease in her lifetime. The stage at which the cancer is detected influences a woman’s likelihood of survival and yearly mammography after the age of 40 enables physicians to identify the smallest abnormalities. In fact, when breast cancer is detected early and limited to the breast, the five-year survival rate is 97%. “Annual screening mammograms starting at the age of 40 saves lives,” concluded Dr. Plecha. “Breast cancers caught in the initial stages by mammography are more likely to be cured and are less likely to require chemotherapy or as extensive surgery.”

Related Links:

University Hospitals Case Medical Center



RADCAL
SuperSonic Imagine
RTI ELECTRONICS AB

Channels

MRI

view channel
Image: The quantitative character of the novel 3D technique on MR scans from a patient with primary liver cancer is demonstrated. Images A and B show the scan of the patient before being treated with chemoembolization. The new 3D technique helped quantify the volume and distribution of viable tumor tissue (shown in red and yellow colors). Images C and D demonstrate MR scans acquired after the treatment. The new 3D method helped the radiologists to quantify the vast central destruction of the tumor after the treatment (the dead tumor is represented by the blue color) (Photo courtesy of Johns Hopkins Medicine).

3D MRI Offers Improved Prediction of Survival After Chemotherapy for Liver Tumors

Researchers are using specialized three-dimensional (3D) magnetic resonance imaging (MRI) scanning technology to accurately measure living and dying liver tumor tissue in order to quickly show whether... Read more

Ultrasound

view channel
Image: Siemens Healthcare has launched the HELX Evolution, the newest iteration of its Acuson S range of ultrasound imaging systems (Photo courtesy of Siemens Healthcare).

Ultrasound Imaging System Enhancements Include High Definition Transducers, Sophisticated Elastography, and Tissue Strain Analysis

New features designed for a range of ultrasound systems include enhanced image quality with a large 21.5-inch liquid crystal diode (LCD) monitor, high definition (HD) transducers, optimized contrast agent... Read more

Nuclear medicine

view channel
Image: Sagittal section of brain PET image at four hours after 64CuCl2 injection with disulfiram or D-penicillamine in MD model mice (Photo courtesy of the RIKEN Center for Life Science Technologies).

PET Imaging Used to Assess Effectiveness of Menkes Disease Treatments

Japanese scientists are using positron emission tomography (PET) imaging to visualize the distribution of copper in the body using lab mice. Copper distribution is deregulated in a genetic disorder called... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Software Designed for the Assessment of Orthopedic Implant Fixation and Bone Segment Motion

Model-based roentgen stereophotogrammetric analysis (MBRSA) software has been developed for evaluation of orthopedic implant fixation and bone segment motion. The software is the first to measure the in vivo three-dimensional (3D) position and/or relative motion of metal implants, markers beads, and/or bone segments in... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.